MOREPENLAB quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Morepen Laboratories Ltd reported sales of ₹746 Cr, operating profit of ₹123 Cr (OPM 16%) and net profit of ₹89 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
MOREPENLAB quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
453
466
425
412
484
485
570
746
Expenses
417
424
401
381
438
460
488
623
Operating Profit
36
42
24
31
46
24
83
123
OPM
8%
9%
6%
7%
10%
5%
14%
16%
Other Income
5
5
4
30
4
8
5
9
Interest
1
5
4
4
4
4
5
5
Depreciation
5
16
9
11
10
6
8
10
Profit before tax
35
26
16
46
35
23
75
117
Tax
24%
21%
26%
10%
22%
33%
24%
24%
Net Profit
27
20
11
41
28
16
56
89
EPS in Rs
0.49
0.37
0.2
0.75
0.5
0.29
1.03
1.62
MOREPENLAB profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
1,547
1,418
1,690
1,812
1,806
2,286
Expenses
1,410
1,338
1,532
1,638
1,680
2,009
Operating Profit
137
80
159
174
126
276
OPM
9%
6%
9%
10%
7%
12%
Other Income
10
6
14
18
47
26
Interest
-7
2
4
8
16
18
Depreciation
28
28
33
29
36
35
Profit before tax
127
56
135
155
120
250
Tax
20%
31%
29%
24%
20%
-
Net Profit
102
39
97
118
96
188
EPS in Rs
2.13
0.76
1.88
2.15
1.73
3.44
Dividend Payout
0%
0%
0%
9%
12%
-
MOREPENLAB balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
102
110
110
110
110
Reserves
745
1,047
1,087
1,137
1,272
Borrowings
29
105
158
208
323
Other Liabilities
417
517
381
482
602
Total Liabilities
1,293
1,778
1,736
1,936
2,306
Fixed Assets
307
489
471
513
583
CWIP
24
28
26
22
23
Investments
1
85
136
124
118
Other Assets
960
1,176
1,104
1,277
1,582
Total Assets
1,293
1,778
1,736
1,936
2,306
MOREPENLAB cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
-60
-91
73
32
33
Cash from Investing Activity
-32
-47
-83
-322
-126
Cash from Financing Activity
66
144
5
300
97
Net Cash Flow
-26
6
-5
10
4
Free Cash Flow
-127
-137
-8
-182
-127
CFO/OP
-26%
-94%
70%
40%
46%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit